A Pathway Towards Ultra-Personalization at Scale

Co-developed by the Catalyzer Think Tank divergent thinking and Gemini Deep Research tool.

Introduction

The intricate tapestry of human experience—woven from threads of thought, feeling, action, and belief—remains one of science’s most profound frontiers. Understanding the dynamic neurophysiological processes underlying these internal states holds transformative potential for enhancing individual well-being, augmenting human capabilities, and shaping the future of human-machine collaboration. Achieving this requires moving beyond superficial observations towards real-time, high-fidelity monitoring of the body’s complex signaling networks. This endeavor sits at the confluence of multiple rapidly advancing fields: sophisticated in vivo sensing technologies capable of probing the autonomic nervous system and blood network; ambitious national research strategies, such as Japan’s Moonshot program aimed at realizing a “Society 5.0”; and novel artificial intelligence paradigms designed to fuse and interpret the resulting torrent of heterogeneous biological data.

This report provides an expert-level analysis of the current landscape and future trajectory of this convergence. It examines the diverse array of in vivo sensors—spanning wearable devices, implantable biosensors, nanoscale constructs, and quantum technologies—that are being developed to capture physiological signals relevant to human internal states.1 It delves into Japan’s Moonshot Research and Development (R&D) program, specifically investigating Goals 1 and 9, which explicitly target the deep understanding of individuals, the augmentation of human potential, and the enhancement of mental well-being through technological means, aligning with the vision of Society 5.0.11 Furthermore, the report scrutinizes cutting-edge AI concepts, including Edge AI, hyperbolic geometry-based representation learning (“hyperbolic lensing”), and advanced associative memory models (“Granular to Geometric Associative Memory” or GGAM), exemplified by platforms like WiSE Relational Edge AI©, assessing their potential to integrate and make sense of complex, multi-modal biosignal data.22

The objective is to synthesize these disparate elements, charting a potential pathway from real-time physiological monitoring to a deeper, more personalized understanding of the individual, and exploring how this capability could underpin the realization of next-generation human-machine societies. This analysis critically evaluates the state-of-the-art, identifies key technological and strategic drivers, and illuminates the significant challenges—technical, ethical, and societal—that must be navigated to responsibly harness the power of these converging technologies.

Section 1: The Landscape of In Vivo Sensors for Monitoring Human Internal States

Achieving a granular understanding of human internal states necessitates monitoring the dynamic activity within key physiological systems. The Autonomic Nervous System (ANS), the blood network carrying neurochemicals and hormones, and direct brain activity provide crucial windows into the biological correlates of thought, feeling, action, and belief. A diverse range of sensor technologies, varying in invasiveness, maturity, and the specific signals they target, are being developed to capture this information in vivo.

1.1 Overview of Relevant Physiological Networks and Target Signals

The Autonomic Nervous System (ANS) operates largely unconsciously, regulating vital functions and mediating responses to internal and external stimuli. It comprises two main branches: the sympathetic nervous system, responsible for the “fight-or-flight” response preparing the body for alertness and action 3, and the parasympathetic nervous system, governing “rest-and-digest” functions and promoting recovery. These systems generally act in a complementary manner, with their dynamic balance reflecting states of arousal, stress, relaxation, and emotional response.2 Key measurable signals reflecting ANS activity include:

• Electrodermal Activity (EDA): Changes in the electrical conductance of the skin, primarily driven by sweat gland activity under sympathetic control.2 EDA provides a sensitive measure of sympathetic arousal and emotional intensity.2
• Heart Rate Variability (HRV): The fluctuation in time intervals between consecutive heartbeats. Higher variability, particularly in the high-frequency (HF) band, generally reflects greater parasympathetic (vagal) influence and is associated with better emotional regulation, stress resilience, and cognitive function.3 Traditional spectral analysis (LF/HF bands) has limitations in separating sympathetic and parasympathetic influences due to overlap, leading to the development of advanced metrics like the Sympathetic Activity Index (SAI) and Parasympathetic Activity Index (PAI) derived from heartbeat timing models.3
• ANS Neurotransmitters: Norepinephrine (NE) is the primary neurotransmitter of the sympathetic postganglionic neurons 9, while Acetylcholine (ACh) is key for the parasympathetic system and preganglionic sympathetic neurons.34 Direct, real-time in vivo measurement of these neurotransmitters, especially within specific nerve terminals or ganglia, remains challenging but offers a more direct probe of branch-specific activity.34

The Blood Network serves as a critical communication highway, transporting hormones released by endocrine glands and neurochemicals that can cross the blood-brain barrier (BBB) or act peripherally, influencing mood, stress levels, and cognitive processes. Relevant signals include:

• CNS/Blood Neurotransmitters: Dopamine (DA) and Serotonin (5-HT) are crucial modulators of mood, motivation, reward, learning, and cognition.7 Monitoring their levels, often present in low concentrations with rapid turnover, poses significant technical hurdles, particularly for real-time measurements.35
• Hormones: Cortisol, the primary glucocorticoid released by the hypothalamic-pituitary-adrenal (HPA) axis in response to stress, significantly impacts cognition, emotion, and immune function.26 Its levels fluctuate throughout the day and in response to various stimuli, including psychological stress.26

Brain Activity Proxies provide insights into neural processing related to cognitive and emotional states:

• Electroencephalography (EEG): Measures summed electrical potentials generated by neuronal populations, typically recorded non-invasively from the scalp. Different frequency bands (e.g., delta, theta, alpha, beta, gamma) are associated with various states like sleep, relaxation, alertness, cognitive effort, and emotional processing.31
• Functional Near-Infrared Spectroscopy (fNIRS): An optical technique that measures changes in oxygenated and deoxygenated hemoglobin concentrations in cortical blood vessels. These hemodynamic changes are correlated with local neural activity, providing a non-invasive way to map brain function, particularly in the prefrontal cortex during cognitive tasks or emotional responses.31

Other signals, such as local temperature and pH, can also provide information about metabolic activity or specific physiological processes and are targets for certain sensor types, particularly quantum sensors.5

It is crucial to recognize that these measurable physiological signals are typically proxies for the complex internal states they aim to represent. EDA reflects arousal, not necessarily the specific emotion causing it 2; HRV indicates autonomic balance, not the content of thought 3; neurotransmitter levels correlate with mood or function but do not equate to a belief.7 Consequently, interpreting these signals requires sophisticated modeling and, ideally, the integration of multiple data streams. The challenge lies in moving beyond simple correlations to build inferential models that can reliably estimate the nuances of thoughts, feelings, and beliefs from these indirect physiological measures.

1.2 Wearable and Skin-Probe Sensors

Wearable sensors represent the most accessible category for continuous, real-time monitoring in everyday environments. These devices, typically worn on the wrist, chest, head, or other body locations, are generally non-invasive or minimally invasive, leveraging contact with the skin surface to capture physiological data.8

Key technologies include:

• EDA Sensors: These sensors measure subtle changes in skin conductance resulting from sweat gland activity, a direct indicator of sympathetic nervous system arousal.2 They are commercially available in various form factors (e.g., wristbands like the mPath MOXO sensor 29) and are widely used in research and consumer applications for tracking stress, emotional intensity, and even cognitive states like rumination.8 Studies suggest EDA can be a comparatively valid biomarker for detecting cognitive rumination via wearables 8 and holds potential for real-time emotion interpretation, reacting within seconds to emotional triggers.28
• ECG/PPG Sensors: Electrocardiography (ECG) sensors measure the heart’s electrical activity, while photoplethysmography (PPG) sensors use light to detect blood volume changes in peripheral tissues. Both can derive heart rate (HR) and HRV.3 These are ubiquitous in consumer smartwatches and fitness trackers 46, providing data for assessing cardiovascular health and autonomic balance. Advanced algorithms, like those calculating SAI and PAI, aim to extract more specific sympathetic and parasympathetic activity indices from beat-to-beat timing derived from these sensors.3
• EEG Sensors: Wearable EEG systems, often integrated into headbands or caps, utilize scalp electrodes to record brain electrical activity.31 While less common in consumer devices than HR/EDA sensors, they are used in research and niche applications for monitoring cognitive states, attention, stress levels, and sleep stages through analysis of frequency band power (delta, theta, alpha, beta).42
• fNIRS Sensors: These optical sensors, typically embedded in headbands, measure changes in blood oxygenation in the outer layers of the brain (cortex), providing an indirect measure of neural activity.31 Primarily a research tool, fNIRS shows promise for monitoring cognitive workload, emotional processing, and brain responses during social interactions or specific tasks, often used in conjunction with EEG.31

Development Stage: Many wearable sensors measuring HR, HRV, and EDA are mature technologies integrated into commercially available consumer products.29 Wearable EEG and fNIRS are more often found in applied research or specialized clinical settings, although consumer-grade versions are emerging.31 The field is dynamic, with ongoing improvements in sensor accuracy, algorithm sophistication, miniaturization, and comfort.46

Challenges: Despite their convenience, wearables face significant hurdles. Signal quality can be compromised by motion artifacts and poor sensor-skin contact.6 Concerns persist regarding the accuracy and reliability of data collected in uncontrolled real-world settings.46 Data privacy and security are paramount given the sensitive nature of physiological information.46 Furthermore, interpreting the complex, often noisy signals to infer meaningful psychological states requires robust algorithms and contextual information, an area where further development is needed.8 Some surveys have even questioned the appropriateness of sensors embedded in early smartphones for mental health applications.46

The primary advantage of wearables lies in their ability to collect longitudinal data unobtrusively in naturalistic settings, offering insights into daily patterns of stress, activity, and potentially mood.2 However, the signals they capture are often indirect measures of the underlying neurophysiology and are susceptible to noise. To overcome these limitations, a trend towards integrating multiple sensor modalities (e.g., EDA + HRV + Temperature) within a single device is apparent, aiming to improve the robustness and contextual richness of the collected data through sensor fusion.

1.3 Implantable Biosensors

For applications demanding higher fidelity access to specific biological targets or measurements from deep within the body, implantable biosensors offer a powerful alternative to wearable devices. These sensors are surgically placed in vivo to directly interface with tissues or biological fluids, enabling longitudinal monitoring of biophysical or biochemical parameters inaccessible from the surface.6

Key technologies include:

• Electrochemical Sensors: These typically employ microelectrodes modified with enzymes or specific surface chemistries to detect target analytes (like neurotransmitters) through electrochemical reactions (oxidation or reduction).7 Techniques like Fast Scan Cyclic Voltammetry (FSCV) and amperometry allow for relatively rapid detection (seconds timescale) of electroactive molecules like dopamine and serotonin.35 Non-electroactive molecules like ACh often require enzymatic conversion (e.g., using acetylcholine esterase – AChE) at the electrode surface to produce a detectable signal (e.g., H2O2 or pH change).7 Research focuses on miniaturization, improving selectivity between structurally similar neurochemicals, enhancing sensitivity (down to nanomolar or micromolar ranges), and developing multi-analyte platforms.7
• Optical Sensors: These leverage changes in light properties (intensity, wavelength, lifetime) to report on biological activity. A prominent example is the development of Genetically Encoded Fluorescent Sensors (GEFS). These are engineered proteins, often based on G protein-coupled receptors (GPCRs) or bacterial periplasmic binding proteins, fused with fluorescent proteins (like cpGFP).9 When the sensor binds its target ligand (e.g., NE for GRABNE sensors 9, ACh for iAChSnFR 35), it undergoes a conformational change that alters its fluorescence. Expressed in specific cell types via viral vectors or transgenic lines, these sensors offer exceptional specificity and high temporal resolution (sub-second) for monitoring neurotransmitter release in vivo.9 Other optical approaches include calcium imaging using indicators like GCaMP to track neural activity 1 and DNA-based nanosensors that use pH-sensitive fluorophores near enzymes to detect neurotransmitter breakdown.34
• Biophysical Sensors: These implants measure physical parameters such as strain, pressure, or temperature within tissues.6 They find applications in orthopedics (monitoring bone healing or implant stability) 6 or tracking temperature changes associated with metabolic activity or inflammation.47
• Neural Interfaces (Implants): These devices directly interface with the nervous system to record or stimulate electrical activity. Examples include electrocorticography (ECoG) grids placed on the brain surface, or penetrating microelectrode arrays inserted into brain tissue to record action potentials from individual neurons or local field potentials from neuronal populations.48 These are the core components of Brain-Computer Interfaces (BCIs) or Brain-Machine Interfaces (BMIs) used for research and clinical applications like restoring motor function or communication.48 Flexible implant materials are being developed to overcome the mechanical mismatch between rigid electrodes and soft neural tissue.48

Development Stage: While simple implantable devices like cardiac pacemakers have been used for decades 6, most advanced implantable biosensors for neurochemical or complex neural recording are still primarily in the applied research or clinical trial phases.1 GEFS, in particular, are rapidly advancing neuroscience research capabilities.9

Challenges: The primary barrier for implantable sensors is their invasiveness, requiring surgery and carrying associated risks. Biocompatibility is a major concern; the body often mounts a foreign body reaction (FBR) against the implant, involving protein adhesion and inflammation, which can degrade sensor performance and stability over time.48 Ensuring long-term performance, reliable power sources (batteries or wireless power transfer), and secure wireless data transmission are significant engineering challenges.1 Achieving high selectivity, especially for electrochemical sensors detecting similar molecules, remains difficult.7

Implantable sensors offer unmatched potential for high-fidelity, localized measurements of specific neurochemical and neural signals directly at their source, providing data crucial for understanding fundamental biological mechanisms and potentially enabling precise diagnostics or therapies.6 However, the substantial hurdles related to invasiveness, long-term stability, and biocompatibility currently restrict their widespread application primarily to research contexts or situations where the clinical need outweighs the risks. The development of GEFS marks a significant leap forward in achieving high specificity and temporal resolution for monitoring neurotransmission in vivo, revolutionizing neuroscience research.9

1.4 Nanoscale Sensors: Nanobots and Nanomaterials

Operating at the ultimate frontier of miniaturization, nanoscale sensors and devices hold immense theoretical promise for interacting with biological systems at the molecular and cellular level in vivo. This category includes engineered nanorobots and functionalized nanoparticles designed for sensing, diagnostics, drug delivery, and therapeutic intervention.4

Key concepts and technologies include:

• Nanorobots: These are envisioned as nanoscale machines (typically 1-100 nm in some dimension) capable of performing specific tasks within the body.51 Conceptual designs often include components for propulsion, sensing (e.g., chemical sensors for biomarkers, pH, temperature), data processing/control (nanocontrollers), actuation, and payload delivery.50 Pioneering work, such as that by Prof. Toshio Fukuda, laid the groundwork for micro/nanorobotics for cell manipulation.51 Propulsion strategies are diverse, utilizing chemical reactions (e.g., enzyme catalysis like urease or glucose oxidase 53, hydrogen peroxide decomposition) or external energy fields (magnetic, acoustic, light) to navigate biological fluids.50 Research examples include enzyme-powered nanobots demonstrating enhanced accumulation in bladder tumors in vivo for potential cancer therapy.53 Materials used must be biocompatible or biodegradable.51
• Artificial Blood Components: A specialized concept within nanorobotics involves designing nanoscale devices to mimic or augment the function of blood cells. Theoretical constructs include “respirocytes” for oxygen transport (artificial RBCs), “microbivores” for pathogen clearance (artificial WBCs), and “clottocytes” for hemostasis (artificial platelets).4 This remains largely a field of theoretical research and early development.
• Nanoparticles for Neurotheranostics: Significant progress has been made in using functionalized nanoparticles (e.g., liposomes, polymers, inorganic NPs) as vehicles to overcome biological barriers, particularly the Blood-Brain Barrier (BBB).54 By carefully engineering size, shape, charge, and surface ligands, nanoparticles can be designed to carry therapeutic agents (drugs, genes) or diagnostic probes into the central nervous system, offering potential for treating neurological disorders.54 This area has seen substantial research growth.54

Development Stage: The field of in vivo nanoscale sensors and robots is predominantly in the theoretical and applied research stages.4 While nanoparticle-based drug delivery systems have seen considerable development and some clinical translation 54, autonomous nanorobots capable of complex sensing and actuation in vivo are still largely conceptual or demonstrated in limited preclinical models.53 Recent publications highlight ongoing work, for instance, on inhalable biohybrid microrobots for lung treatment.55

Challenges: Translating nanoscale devices into practical in vivo applications faces immense challenges. Ensuring biocompatibility and avoiding toxicity are paramount.51 Achieving reliable control, navigation, and targeting within the complex and dynamic biological environment is extremely difficult.50 Providing power for active nanorobots remains a major hurdle. Manufacturing these complex devices at scale is another significant obstacle. Furthermore, the potential for unintended consequences and the ethical implications of deploying autonomous nanoscale agents within the human body require careful consideration.52

Nanoscale sensors and robots represent a long-term vision with the potential to revolutionize medicine through highly targeted, minimally invasive interventions at the cellular level. Their ability to potentially sense local microenvironments, deliver drugs precisely, or even perform nanoscale surgery is compelling.51 However, the path from current research to clinical reality is long and requires overcoming fundamental challenges in control, power, biocompatibility, and demonstrating safety and efficacy within the complexities of living organisms. The current research emphasis appears to be shifting from demonstrating basic motility to integrating functional capabilities like sensing and delivery, and validating these functions in relevant biological models.50

1.5 Quantum Sensors in Biology

A new class of sensors leverages the principles of quantum mechanics—such as quantum coherence, entanglement, and discrete energy levels—to achieve measurement sensitivities and spatial resolutions potentially surpassing classical limits.44 These quantum sensing technologies hold promise for probing biological systems with unprecedented precision and minimal invasiveness.

Key technologies and principles include:

• Nitrogen-Vacancy (NV) Centers in Diamond: These are atomic-scale defects in the diamond lattice where a nitrogen atom and an adjacent vacancy replace two carbon atoms.56 NV centers possess electron spins that can be initialized, manipulated with microwaves, and read out optically (via fluorescence).5 Crucially, the spin state, and thus the fluorescence intensity, is highly sensitive to the local environment, including magnetic fields, electric fields, temperature, and pH.5 A key advantage is their ability to operate under ambient conditions (room temperature and pressure), making them suitable for biological applications.45 By incorporating NV centers into nanodiamonds (NDs), biocompatible nanoscale sensors can be created and introduced into living cells or organisms to probe local conditions, such as intracellular temperature gradients during biological processes like cell division or endogenous heat generation.5 Various instrument configurations exist, including scanning probe microscopes using a single NV center on an AFM tip for high-resolution magnetic field imaging, compact vectorial magnetometers using NV ensembles for sensitive field measurements (potentially for GPS-free navigation or medical applications), and wide-field magnetometers for imaging magnetic fields across a sample.56 Integrated platforms like the Q-BiC microelectronic chip aim to combine microwave delivery, temperature control, and microfluidics for streamlined biological quantum sensing.5 NV centers are also being explored for nanoscale Nuclear Magnetic Resonance (NMR) spectroscopy, potentially enabling structural analysis of single molecules or metabolic studies in single cells.59
• Quantum Light: Classical optical measurements are fundamentally limited by shot noise, which arises from the quantum nature of light detection. Quantum optics offers techniques to overcome this limit by using non-classical states of light, such as squeezed states or N00N states.44 These states exhibit reduced noise in certain properties (e.g., intensity or phase) below the shot noise level. Applying quantum light sources in biological imaging or spectroscopy could allow for achieving the same signal-to-noise ratio with significantly lower light intensity, thereby reducing the risk of phototoxicity or sample damage, which is crucial when studying delicate biological systems.44 This enables higher precision measurements with minimal invasiveness.44
• Quantum Biology and Related Technologies: The emerging field of quantum life science explores whether quantum phenomena like tunneling, superposition, and entanglement play functional roles in biological processes such as photosynthesis, enzyme catalysis, or magnetoreception.45 While distinct from engineered quantum sensors, understanding these processes could inspire new sensing approaches. Related quantum technologies being developed for biological investigation include quantum-enhanced hyperpolarized MRI/NMR, which uses nuclear spin manipulation to boost signal strength for metabolic imaging.45

Development Stage: Quantum sensing, particularly using NV centers, is rapidly transitioning from fundamental physics experiments and proof-of-principle demonstrations towards applied research in biology and early commercialization.45 Several start-up companies are now commercializing NV-based magnetometers, NMR systems, and imaging platforms for biomedical research and diagnostics.59 Quantum light applications in biology are generally at an earlier stage of development.44

Challenges: Despite the promise, significant challenges remain. Integrating the necessary quantum control elements (e.g., microwave delivery for NV centers) and optical readout systems with living biological samples without causing damage or perturbation is a key hurdle.5 Identifying microwave power thresholds for stress-free operation in cells is crucial.5 Further improvements in sensitivity are needed for demanding applications like single-molecule detection or mapping weak biomagnetic fields.59 Miniaturization, cost reduction, and developing user-friendly instrumentation are essential for broader adoption and commercial success.59

Quantum sensing offers a paradigm shift in measurement science, providing tools to probe biological systems with potentially unparalleled sensitivity and spatial resolution, down to the nanoscale.5 NV centers in diamond represent the most mature platform for in vivo and in vitro biological applications currently, capable of measuring multiple physical parameters locally and non-invasively. The fundamental advantage lies in the ability to investigate biological processes with high precision while minimizing disturbance, aligning perfectly with the goal of achieving a deeper, more accurate understanding of complex living systems.44

1.6 Table 1: In Vivo Sensor Technologies Overview

The following table summarizes the key characteristics of the diverse in vivo sensor technologies discussed, providing a comparative overview relevant to monitoring physiological signals associated with human internal states.

 

Sensor Type	Primary Signal(s) Measured	Principle Mechanism	Development Stage	Relevance to Cognition/Emotion/Behavior/Belief Proxies	Key Snippets
Wearable/Skin-Probe	EDA, HRV, HR, EEG Rhythms, Cortical Hemodynamics (fNIRS)	Skin Conductance, Beat Timing/PPG, Scalp Electrodes, Near-Infrared Light Absorption	Commercial / Research	Arousal, ANS Balance, Stress, Cognitive State, Emotional Processing, Attention	2
Implantable-Electrochemical	Neurotransmitters (DA, 5-HT, NE, ACh), pH, O2	Redox Reactions (Direct or Enzyme-Mediated), Ion-Selective Electrodes	Research / Clinical Trials	Mood, Motivation, Stress Response, ANS Activity, Neural Communication	7
Implantable-Optical	Neurotransmitters (NE, ACh, DA), Ca2+ (Neural Activity)	Genetically Encoded Sensor Fluorescence Change, Calcium Indicator Fluorescence	Research / Preclinical	Specific Neurotransmitter Dynamics, Neural Activity Patterns, Learning, Memory, ANS Function	1
Implantable-Neural Interface	Neural Spikes (Action Potentials), Local Field Potentials (LFPs)	Direct Electrical Recording from Neurons/Brain Tissue	Research / Clinical	Neural Processing, Brain States, Cognitive Tasks, Motor Control (BMI), Sensory Processing	48
Nanoscale-Robot/Material	Biomarkers, pH, Temperature, Specific Molecules	Chemical Sensing, Targeted Binding, Enzyme Catalysis, Physical Property Detection	Theory / Research	Targeted Disease Detection, Local Microenvironment Sensing, Drug Delivery Monitoring, Artificial Organ Function (Future)	4
Quantum-NV Center	Magnetic Field, Electric Field, Temperature, pH, Spin States	NV Center Electron Spin State Readout (Optical Fluorescence)	Research / Early Comm.	Nanoscale Temperature/pH in Cells, Neural Activity (Magnetic Field), Molecular Structure (NMR), Metabolomics	5

Note: Development stages are approximate and can vary within categories. Relevance indicates potential links between measured signals and higher-level states, often requiring complex interpretation.

1.7 Synthesis: Current Capabilities and Limitations in Real-Time Monitoring of Psycho-physiological States

The landscape of in vivo sensing for monitoring internal states reveals a field rich with innovation but also marked by a significant gap between readily available technologies and the ultimate goal of comprehensively understanding human thought, feeling, and belief.

Current Capabilities: Non-invasive wearable sensors provide unprecedented opportunities for longitudinal monitoring of ANS correlates like EDA and HRV in real-world settings, offering valuable data on stress, arousal, and sleep patterns.2 In research environments, advanced implantable systems, particularly electrochemical and optical sensors (including GEFS), allow for high-fidelity, real-time measurement of specific neurochemicals (NE, ACh, DA, 5-HT) and direct neural activity within targeted brain regions or peripheral nerves.1 Progress is being made in developing sensors capable of detecting multiple analytes simultaneously.36 Quantum sensors, especially NV centers, are emerging as powerful tools for probing biological processes at the nanoscale with high sensitivity.5 Nanotechnology offers a long-term vision for highly targeted sensing and intervention at the cellular level.4

Limitations: A major challenge is bridging the gap between the potential demonstrated in controlled laboratory settings and the development of robust, reliable, and widely deployable systems for real-world use.46 Wearable sensors often suffer from issues of accuracy, signal artifacts, and the indirect nature of their measurements.6 Implantable sensors face significant hurdles related to invasiveness, biocompatibility (FBR), long-term stability, power, and data transmission.1 Nanoscale and quantum sensors, while promising, are largely still in earlier stages of development and face their own unique integration and validation challenges.5 Crucially, even the most advanced sensors currently measure physiological proxies. Directly measuring subjective states like “thoughts” or “beliefs” remains beyond current capabilities; these must be inferred from patterns in the physiological data. This inference process requires sophisticated data analysis, multi-modal fusion techniques, and robust validation against ground truth measures (e.g., subjective reports, behavioral observation).31 Finally, the prospect of continuous internal state monitoring raises profound ethical concerns regarding privacy, autonomy, and potential misuse that must be addressed proactively.46

The field is thus characterized by a fundamental tension: the convenience and accessibility of wearable sensors often come at the cost of signal directness and fidelity, while the high specificity and resolution offered by implantable, nano-, and quantum sensors are currently offset by invasiveness, complexity, and developmental stage. Progress towards the goal of deeply understanding individual human states necessitates parallel advancements in sensor technology—making them less invasive, more stable, more accurate, and capable of multi-analyte detection—and in the sophisticated AI and machine learning algorithms required to extract meaningful, personalized insights from the complex, noisy, and multi-modal data streams these sensors generate. Capturing the “principal components of how people think/feel/act/believe,” as queried by the user, will depend heavily on the power of these inferential models built upon the foundation of physiological proxy measurements.

Section 2: Japan’s Moonshot R&D Program: Towards Deep Human Understanding and Society 5.0

Japan’s Moonshot Research and Development Program represents a significant national commitment to fostering disruptive, high-impact innovation aimed at addressing pressing societal challenges and shaping a desirable future. Central to this vision is the concept of “Society 5.0,” a human-centered society that leverages the integration of cyberspace and physical space. Several Moonshot Goals, particularly Goals 1 and 9, are directly relevant to the quest for deeper human understanding through advanced sensing and AI.

2.1 Overview of Moonshot Goals and the Vision for Society 5.0

Launched by the Japanese government, the Moonshot R&D Program promotes ambitious, high-risk, high-impact research projects designed to achieve radical solutions for major societal issues by 2050.12 It operates with significant government funding (over 100 billion yen allocated for the first five years) and encourages bold ideas that leap beyond conventional technological trajectories.12 The program explicitly aims to address challenges such as Japan’s declining birthrate and aging population, large-scale natural disasters, and environmental concerns, ultimately striving to enhance global human well-being.13

The Moonshot initiative is deeply intertwined with Japan’s vision for Society 5.0. Proposed in the 5th Science and Technology Basic Plan, Society 5.0 envisions a future “human-centered society” where economic development and the resolution of social problems are achieved simultaneously through the sophisticated integration of cyberspace and physical space.14 Key elements include the use of digital twins, the integration of diverse knowledge domains including Ethical, Legal, and Social Implications (ELSI) – termed “Convergence Knowledge” or “So-Go-Chi” – and the development of human resources capable of creating value in this new societal paradigm.14 Technologies like AI, IoT, robotics, and big data analytics are seen as crucial enablers. The Moonshot program is explicitly positioned as a key driver for realizing this Society 5.0 vision.14 This strategic context is vital: the technological goals pursued under Moonshot are not ends in themselves but are intended as means to achieve a specific, human-centric socio-economic transformation designed to address Japan’s unique demographic and societal challenges while promoting overall well-being.

2.2 Moonshot Goal 1: Overcoming Limitations – Cybernetic Avatars, BMI, and In-Body Sensing

Moonshot Goal 1 is arguably the most ambitious in its aim to directly augment human capabilities: “Realization of a society in which human beings can be free from limitations of body, brain, space, and time by 2050”.11 The core technological concept underpinning this goal is the Cybernetic Avatar (CA). CAs are defined broadly as technologies, encompassing both physical avatars/robots and potentially cyborg-like integrations, designed to expand human physical, cognitive, and perceptual abilities.11 The vision includes:

• Socio CAs: Externally controlled avatars or robots allowing individuals to participate in social activities (work, education, daily life) remotely, overcoming geographical or physical constraints.11 The aim is for seamless teleoperation, potentially allowing one person to control multiple avatars.61
• In-body / Intracellular CAs: Miniaturized avatars operating within the human body, potentially at the micro-, nano-, or even intracellular scale, for continuous health monitoring, early disease detection, and targeted therapeutic interventions.11

Achieving this vision heavily relies on advanced sensor technologies integrated within specific R&D projects 20:

• Kanai Project (“Internet of Brains” – IoB): This project focuses on developing CAs that can be controlled intuitively via the user’s intention. This intention is to be estimated by integrating data from brain activity (using Brain-Machine Interfaces – BMI) with information observed on the surface of the human body (physiological sensors) and interaction data.11 The project explicitly explores non-invasive (e.g., EEG-based), minimally invasive, and potentially invasive BMI approaches, coupled with AI for decoding thoughts related to words and actions.64 The ultimate aim is a BMI-CA that operates seamlessly as an extension of the user’s will by 2050.62 This directly employs neural and physiological sensors as the primary input for controlling the avatars.
• Arai Project (In-body CAs): This project targets the development of millimeter-, micro-, and nanoscale CAs that can be distributed and coordinated within the body to structure spatio-temporal environmental information, enabling continuous health monitoring and ultra-minimally invasive diagnostics.11 These in-body CAs inherently function as mobile, potentially networked, in vivo biosensors, collecting data from deep within the body for health maintenance and disease prevention, envisioned for everyday use by 2050.11
• Yamanishi Project (Intracellular CAs): Pushing the boundaries further, this project aims to create intracellular CAs—nanoscale avatars operating inside individual cells.11 These CAs would be remotely controlled by specialists to “patrol” the body at the cellular level, inspect cells for signs of disease (e.g., malignancy), potentially remove problematic cells, and maintain overall health.11 This represents the ultimate vision of targeted in vivo sensing and intervention, requiring highly sophisticated nanoscale biosensors and actuators.
• Minamizawa Project: This project focuses on using CAs to expand physical and perceptual capabilities and enable the sharing of complex skills and experiences between individuals.11 While less explicit about sensor types, capturing and translating skills likely requires sophisticated motion capture, physiological sensing, and potentially even BMI technologies to transfer embodied knowledge.

Moonshot Goal 1 thus represents a highly integrated strategy where advanced sensing technologies are not merely auxiliary but fundamental building blocks. BMI based on neural and physiological sensors provides the control interface for external avatars, while micro-, nano-, and intracellular CAs act as the sensing (and potentially actuating) elements for internal health management. This multi-scale approach signifies an exceptionally ambitious vision for human-technology integration, pushing the frontiers of BCI/BMI and in vivo sensing far beyond current capabilities to directly create interfaces between humans and machines at the level of the whole body, organs, and even individual cells.

2.3 Moonshot Goal 9: Realizing a Mentally Healthy Society – Monitoring and Supporting Mental States

Complementing the focus on physical and cognitive augmentation in Goal 1, Moonshot Goal 9 addresses the critical dimension of psychological well-being: “Realization of a mentally healthy and dynamic society by increasing peace of mind and vitality by 2050”.12 This goal tackles issues like stress, anxiety, depression, and social isolation, exacerbated by modern life and events like the COVID-19 pandemic.65 The core strategy involves:

• Developing a scientific, objective understanding of diverse mental states (e.g., happiness, positivity, stress, anxiety, curiosity, empathy).
• Creating technologies to monitor and visualize these mental states in individuals and groups, moving beyond subjective self-reports.
• Developing interventions and support systems to help individuals transition towards desired mental states, fostering “peace of mind and vitality” and promoting positive interpersonal communication.21

This goal explicitly relies on the development and application of sensor technologies combined with AI to achieve objective mental state assessment 21:

• Imamizu Project (Overall PD Direction): The Program Director emphasizes discovering the mechanisms behind mental states and using this knowledge to create technologies that generate positive mental transitions.21 The approach involves understanding mental status based on a range of data, explicitly including biological information extracted using sensors and other measuring equipment.65
• Yamada Project (“Maemuki” Life): This project aims to calculate objective indices of “positivity” by measuring physical posture and brain/physiological reactions.21 This directly involves using physiological sensors to quantify a specific aspect of mental state.
• Kikuchi Project (Children’s Curiosity): This project plans to use brain imaging technology (requiring sensors) to analyze children’s brain characteristics related to intellectual curiosity and resilience, visualizing the effects of interventions like artistic activities.21
• Nakamura Project (AIoT Emotion Space): This project seeks to construct a universal emotional state space by integrating AI with Internet of Things (IoT)-based measurements of biological signals collected during daily life.21 This clearly indicates the use of diverse, potentially wearable or environmental, biosensors for continuous emotional state monitoring.
• Takumi Project (Neuroscience of Mind): While using mouse models, this project aims to visualize brain functional network dynamics (using neuroscientific sensors and techniques like optogenetics) to quantify the “state of mind” during social communication, providing foundational knowledge for understanding human mental states.21
• Matsumoto Project (Measuring Happiness): This project has the ambitious goal of developing innovative technology to measure interpersonally comparable indicators of “happiness” directly from brain/neural activity.21 This directly targets the use of brain sensors for quantifying subjective well-being.
• Hosoda Project (Food and Emotion): This project investigates the neuroscientific mechanisms (implying sensor-based measurements in animal models) by which food induces positive emotions and influences preferences, aiming to use food as a tool to increase mental comfort and vitality.21

Moonshot Goal 9 directly addresses the core of the user’s query regarding the understanding of thoughts, feelings, and beliefs by aiming for objective, biologically grounded measurement and modulation of complex mental states like “happiness,” “positivity,” and “vitality.” The strategy explicitly depends on leveraging various sensor modalities—including physiological sensors, brain imaging techniques, and IoT-based biosignal collection—coupled with sophisticated AI analysis. This represents a significant push towards moving the assessment of mental well-being from purely subjective scales to more quantitative, neurophysiologically informed methods.

2.4 Table 2: Relevant Japan Moonshot Projects for Human Understanding and Augmentation

The following table highlights key projects within Moonshot Goals 1 and 9 that are particularly relevant to the development and application of advanced sensors and AI for deep human understanding, augmentation, and well-being.

 

Moonshot Goal	Project PM / Title (Abbreviated)	Key Objectives	Sensor/AI Technologies Mentioned	Key Snippets
Goal 1	Kanai / Internet of Brains (IoB)	Control CAs via intention; Overcome limitations; Enable remote participation; Ultimate BMI-CA by 2050.	BMI (non-invasive, minimally invasive, invasive), EEG, Body surface sensors, AI for intention estimation/decoding.	11
Goal 1	Arai / In-body CAs	Visualize health state via distributed in-body CAs; Health monitoring & ultraminimally invasive diagnostics.	Millimeter-, micro-, nanoscale in-body CAs (functioning as biosensors), Coordinated sensing.	11
Goal 1	Yamanishi / Intracellular CAs	Extend immune capabilities via intracellular CAs; Patrol body, inspect/remove diseased cells; Increase healthspan.	Intracellular CAs (functioning as biosensors/actuators), Remote control, Cellular-level sensing.	11
Goal 1	Minamizawa / Skill/Experience Sharing	Expand physical/perceptual capabilities; Share skills/experiences via CAs; Enable co-creation.	CAs, Implicit need for sensors capturing skills/experiences (motion, physiological, potentially BMI).	11
Goal 9	Imamizu / PD Direction	Understand mental state mechanisms; Develop tech for positive mental transitions; Increase peace & vitality.	Biological information from sensors, AI for analysis, Multidisciplinary approach (neuroscience, humanities).	21
Goal 9	Yamada / Maemuki (Forward-Looking) Life	Calculate “positivity” indices; Establish tech to assist/train positivity factors.	Physical posture sensors, Brain/physiological reaction sensors, AI for index calculation.	21
Goal 9	Kikuchi / Children’s Curiosity	Analyze children’s brain characteristics; Visualize intervention effects; Prevent self-esteem damage.	Brain imaging technology (sensors), AI for analysis.	21
Goal 9	Nakamura / AIoT Emotion Space	Construct universal emotional state space; Evaluate well-/ill-being states.	IoT-based biological signal sensors (daily life), AI for state space modeling.	21
Goal 9	Matsumoto / Measuring Happiness	Measure interpersonally comparable “happiness” indicators; Enhance well-being and agency.	Brain/neural activity sensors, AI for indicator development.	21
Goal 9	Takumi / Neuroscience of Mind (Mouse Model)	Visualize brain network dynamics during social communication; Understand “state of mind” mechanisms.	Neuroscience sensors (e.g., imaging, electrophysiology in mice), VR, Optogenetics, AI for network analysis.	21
Goal 9	Hosoda / Food and Emotion	Elucidate mechanisms of food-induced positive emotions; Develop tech to improve food preference/enjoyment.	Neuroscientific methods (implying sensors in animal models), AI for analysis.	21

2.5 Role of Advanced Sensors in Achieving Moonshot Ambitions for Personalized Understanding and Societal Transformation

Across both Goal 1 and Goal 9, advanced sensor technologies emerge not just as useful tools, but as indispensable enabling technologies for realizing Japan’s Moonshot ambitions. They are the crucial first link in the chain, providing the raw data upon which the entire vision of augmented capabilities, enhanced well-being, and ultimately, Society 5.0, is built.

For Goal 1, sensors are the senses of the Cybernetic Avatars. BMI sensors translating neural and physiological signals into intention are required for intuitive control.62 In-body and intracellular sensors are the avatars themselves, acting as vigilant monitors and potential effectors within the biological landscape.11 Without these sensing capabilities, the concept of overcoming physical limitations or achieving granular internal health monitoring remains purely theoretical.

For Goal 9, sensors provide the objective window into the previously subjective realm of mental states.21 By moving beyond self-report to measure physiological correlates and brain activity associated with happiness, positivity, stress, or curiosity, these projects aim to build a more scientific foundation for understanding and supporting mental well-being.21 This objective measurement is seen as key to developing personalized interventions and fostering a society characterized by greater “peace of mind and vitality”.21

The overarching goal is a shift towards deep personalized understanding. Whether it’s decoding an individual’s intention to control an avatar 64, monitoring their unique physiological state via in-body CAs 11, or assessing their specific mental state profile 21, the emphasis is on moving away from population averages towards tailored insights and interventions. Continuous, multi-modal data streams from advanced in vivo sensors are the prerequisite for building such personalized models.

This deep understanding, enabled by sensors and interpreted by AI, is positioned as a cornerstone of the societal transformation envisioned in Society 5.0.14 Augmented capabilities provided by CAs (Goal 1) aim to create a more inclusive society where physical limitations are less restrictive, potentially boosting productivity and resilience.11 Enhanced mental well-being fostered by the technologies of Goal 9 aims to create a more dynamic, harmonious, and vital society.21

Therefore, Japan’s Moonshot program represents a unique, large-scale strategic investment predicated on the belief that deep technological integration—fueled by advanced in vivo sensing and sophisticated AI—can fundamentally reshape society. The explicit pursuit of technologies like BMI, alongside in-body, and even intracellular sensors, signals an exceptionally forward-looking and potentially transformative long-term vision for human-technology symbiosis, aimed squarely at addressing national challenges and enhancing human potential and well-being on an unprecedented scale.

Section 3: Advanced AI for Integrating Heterogeneous Biosignals

The successful deployment of diverse in vivo sensors generates vast streams of complex, multi-modal data. Extracting meaningful insights about an individual’s internal state from this data deluge requires moving beyond traditional analysis techniques towards advanced Artificial Intelligence (AI) methods capable of handling heterogeneity, noise, temporal dynamics, and underlying relational structures. Specific AI concepts like Edge AI, hyperbolic geometry, and associative memory models are emerging as potential components of such sophisticated interpretation frameworks.

3.1 The Challenge: Fusing Diverse, Noisy, Multimodal, Real-Time In Vivo Sensor Data

Data originating from the various sensors discussed in Section 1 presents significant analytical challenges. Streams differ fundamentally in their modality (e.g., electrical signals from EEG/ECG, chemical concentrations from biosensors, optical signals from fNIRS or GEFS, physical parameters like temperature or pressure). They operate on vastly different timescales, from the millisecond resolution of neural spikes or GEFS signals to the slower fluctuations of hormones like cortisol measured over minutes or hours. Signal quality varies significantly, with wearable sensor data often contaminated by noise and motion artifacts, while even implantable sensors face challenges like drift and biofouling. Most importantly, the physiological meaning of each signal is distinct, reflecting activity in different systems (ANS, CNS, endocrine).

The core challenge, therefore, is to integrate these heterogeneous, often noisy, time-varying data streams into a coherent, dynamic model of an individual’s overall psycho-physiological state. This model should ideally capture the complex interplay between different systems—how autonomic activity relates to hormonal changes and brain states during specific cognitive or emotional experiences. Traditional approaches often analyze signals in isolation or rely on simple linear correlations, failing to capture the richness and non-linearity inherent in biological systems. To truly approach an understanding of “how people think/feel/act/believe,” as posed in the user query, requires AI capable of fusing these disparate pieces of information, recognizing complex patterns, understanding context, and operating effectively in real-time. Standard machine learning algorithms may struggle with the high dimensionality, potential sparsity, inherent noise, complex temporal dependencies, and likely hierarchical nature of comprehensively integrated biosignal data.

3.2 Edge AI: Principles and Relevance for Real-Time Biosignal Processing

Edge AI refers to the practice of deploying and executing AI algorithms, particularly machine learning models, directly on or near the edge devices where data is generated—such as sensors, wearables, or local gateways—rather than transmitting all raw data to a centralized cloud server for processing.22 This paradigm shifts computation closer to the data source.

The primary benefits of Edge AI are highly relevant for in vivo sensing applications:

• Reduced Latency: Processing data locally minimizes the round-trip time to a remote server, enabling near-instantaneous analysis and feedback. This is critical for applications requiring real-time responses, such as closed-loop neurostimulation, immediate stress alerts, or controlling prosthetic devices or cybernetic avatars based on rapidly changing neural signals.22
• Decreased Bandwidth Consumption: Continuously streaming high-frequency raw data from multiple biosensors can consume significant network bandwidth. Edge AI allows for local pre-processing, feature extraction, or even full inference, reducing the amount of data that needs to be transmitted.22
• Enhanced Data Privacy and Security: Physiological data is highly sensitive. Processing it locally on a user’s device or a secure edge node reduces the exposure risks associated with transmitting raw data over networks to potentially vulnerable cloud platforms.67
• Improved Reliability: Edge processing can continue even if network connectivity to the cloud is intermittent or unavailable, crucial for critical health monitoring or control applications.67

For the envisioned systems involving continuous monitoring of multiple in vivo signals to understand complex human states or control external devices like CAs, Edge AI is not merely an optimization but a foundational necessity. The stringent requirements for low latency in control loops 48, the need for privacy in handling sensitive health data 67, and the practical constraints of bandwidth for continuous multi-sensor streaming 22 make local processing essential. Edge AI provides the necessary infrastructure to perform sophisticated analysis directly where the data originates, enabling timely, secure, and robust operation of these advanced human-technology systems.

3.3 Hyperbolic Geometry and Lensing in AI: Representing Hierarchical Relationships in Biological and Cognitive Data

Traditional AI and machine learning methods predominantly operate within Euclidean geometry—the familiar geometry of flat space. However, many real-world datasets, particularly those involving complex relationships or inherent hierarchies, may be represented more efficiently and accurately in non-Euclidean spaces, specifically hyperbolic geometry.69 Hyperbolic spaces exhibit constant negative curvature and possess the property of expanding exponentially with distance from a central point, unlike the polynomial expansion of Euclidean space.69 This exponential growth makes hyperbolic spaces naturally suited for embedding tree-like structures or data exhibiting power-law distributions with significantly less distortion and often using lower-dimensional representations compared to Euclidean embeddings.69

This property has led to growing interest in applying hyperbolic geometry to various AI tasks, including:

• Knowledge Graph Embeddings: Representing entities and relationships in large knowledge graphs, which often contain hierarchical structures (e.g., taxonomies).70 Models like FHRE propose using Lorentz rotations directly within hyperbolic space.72
• Graph Neural Networks (GNNs): Developing GNN architectures that operate on graph data embedded in hyperbolic space to better capture hierarchical relationships.69
• Natural Language Processing: Utilizing hyperbolic representations in models like transformers, potentially capturing semantic hierarchies more effectively.69

The relevance to biosignal analysis and cognitive modeling stems from the observation that biological systems and cognitive processes often exhibit inherent hierarchical organization. Examples include the branching structure of the nervous system, metabolic pathways, phylogenetic trees, conceptual taxonomies in the mind, or the hierarchical nature of decision-making processes. Embedding data from in vivo sensors or derived cognitive states into hyperbolic spaces could potentially allow AI models to capture these underlying structures more faithfully and efficiently than standard Euclidean approaches.

The term “Hyperbolic Lensing” is specifically mentioned by IPVIVE as a technique used in their WiSE platform.25 While this term has specific meanings in physics related to hyperbolic metamaterials 24, its usage in the AI context by IPVIVE is not formally defined in publicly available literature.25 Metaphorically, it likely refers to the use of hyperbolic geometry’s properties to “focus” on, magnify, or reveal latent relational structures and hierarchies within complex, multi-modal datasets. This could involve techniques that leverage the way distances and structures are represented in hyperbolic space to identify significant patterns or relationships that might be obscured in a Euclidean representation.

Therefore, hyperbolic geometry presents a promising mathematical framework for AI dealing with the complex, potentially hierarchical nature of integrated biological and cognitive data. While the specific implementation of “hyperbolic lensing” remains proprietary to IPVIVE, the underlying principle of using hyperbolic space’s unique properties to better model relational structures aligns well with the challenge of interpreting multifaceted in vivo sensor data for deeper human understanding.

3.4 Associative Memory Models: From Foundational Concepts to Granular/Geometric Approaches (GGAM)

Associative Memory refers to a class of memory systems, both biological and artificial, that store and retrieve information based on the relationships or associations between data elements, rather than relying on explicit addresses like conventional computer memory.73 A key concept is Content-Addressable Memory (CAM), where data is retrieved based on its content or a part of its content.74 Associative memories excel at pattern completion (recalling a full pattern from a partial or noisy input – auto-association) and pattern mapping (linking one type of pattern to another – hetero-association).74 These concepts are fundamental to how biological brains learn and recall, and they have inspired various artificial neural network models. Modern large language models (LLMs) and transformers can be viewed as implementing sophisticated forms of associative memory, learning vast webs of semantic connections from training data.73

Building on these foundational ideas, more specialized associative memory models have been proposed:

• Geometric Associative Memories (GAMs): Some research explores associative memory models incorporating principles from geometric algebra. These GAMs have shown potential for efficiently restoring patterns affected by various types of noise (additive, subtractive, mixed).23

The term “Granular to Geometric Associative Memory (GGAM)” is another specific concept highlighted by IPVIVE in their WiSE platform description.25 Again, lacking public technical specifications 25, its meaning must be inferred from the name and context. It likely describes a sophisticated associative memory architecture characterized by:

• Granularity: The ability to form associations across different levels of data abstraction, potentially linking fine-grained sensor readings (e.g., specific heartbeat intervals, momentary skin conductance fluctuations) to intermediate physiological patterns (e.g., stress signatures) and further to higher-level cognitive or emotional state interpretations.
• Geometric Structure: The incorporation of geometric principles (possibly related to the hyperbolic geometry used in “lensing,” or concepts from GAMs) to structure the memory and the associations within it. This geometric structure might help organize the relationships between diverse data types more effectively or enable more robust pattern matching and retrieval.

Associative memory models appear particularly well-suited to the task of fusing heterogeneous biosignals. They provide a natural framework for learning and representing the correlations and potential causal links between different physiological events (e.g., associating a specific pattern of increased heart rate, decreased HRV, and elevated EDA with a subjective report of anxiety). A GGAM-like system, as conceptualized, could potentially build these associative links across multiple data modalities and levels of complexity, using a geometric framework to manage the relationships within this multi-layered representation.

Associative memory thus offers a powerful computational paradigm for implementing the “relational intelligence” needed to connect disparate data points into a meaningful whole. GGAM, within the IPVIVE context, likely represents a specific, proprietary implementation aiming to leverage geometric representations (perhaps hyperbolic) within this paradigm to bridge the gap between raw sensor data and high-level understanding of individual states.

3.5 WiSE Relational Edge AI©: A Case Study in Integration

IPVIVE’s WiSE Relational Edge AI© platform serves as a pertinent, albeit proprietary, case study illustrating how the aforementioned advanced AI concepts might be integrated to address the challenge of interpreting complex biosignals for deep personalization.25 Described as a “personalization engine and complex adaptive system architecture,” WiSE© explicitly claims to leverage “machine learning plus the mathematics of personalization and relational intelligence”.25

Key claimed capabilities and components include:

• Core Technology: Uses WiSE Relational Edge AI©, deploying AI processing locally 25, aligning with the Edge AI principles discussed earlier.
• Advanced AI Techniques: Explicitly states the use of hyperbolic lensing and GGAM (granular to long-chained geometric associative memory) machine learning to uncover contextual insights from complex, sparse, multi-modal data, including imperfect and dynamic signals.25
• Focus on Relationships: Aims to unlock “conscious relational intelligence” and understand hidden relationships and cycles within data, knowledge, and ideas.25
• Operational Architecture: Mentions a unique “fast cycle” (identifying divergent triggers) and “slow cycle” (integrating established principles, guided learning, verification) architecture.25
• Human-Machine Synergy: Conceptualizes its function through features like “WiSE Super Sensing©” (data acquisition/interpretation), “WiSE Super Judgment©” (decision support), “WiSE Ultra-Personalized Nudges©” (feedback/guidance), and “WiSE Super-Verification©” (knowledge consolidation).25

Analysis: The WiSE© platform, as described by IPVIVE, directly addresses the user’s query by proposing a system that “glues” heterogeneous signals together using the specific combination of Edge AI, hyperbolic lensing, and GGAM. Its explicit focus on “Relational Intelligence”—understanding the connections and context within complex data—aligns strongly with the goal of creating a holistic, personalized “global lens” on an individual’s state. The platform is positioned as a solution for navigating complexity and enabling better decision-making through human-machine synergy.25

Important Caveat: It is crucial to emphasize that this analysis is based solely on IPVIVE’s publicly available marketing materials and conceptual descriptions.25 No peer-reviewed technical papers, white papers, or detailed algorithmic explanations confirming how WiSE© implements hyperbolic lensing or GGAM, nor independent validation data demonstrating its claimed capabilities, were found in the provided research materials or readily accessible public domain.25 Therefore, WiSE© serves as a compelling conceptual illustration of how these advanced AI techniques might be combined, rather than a scientifically validated example.

Nonetheless, IPVIVE’s WiSE platform provides a tangible (though proprietary) vision for how Edge AI, potentially novel geometric representation techniques (“hyperbolic lensing”), and advanced associative memory structures (“GGAM”) could theoretically converge. Its conceptual framework centered on relational intelligence offers a concrete example of an architecture designed specifically for the complex task of integrating diverse biosignals to achieve deep, personalized understanding, closely matching the user’s articulated goals.

3.6 Theoretical Potential of Combining these AI Techniques for Multi-Sensor Data Fusion and Personalized Modeling

The true power for interpreting complex in vivo sensor data likely lies not in any single AI technique, but in the synergistic combination of approaches like Edge AI, hyperbolic geometry, and associative memory. Each addresses a critical piece of the puzzle:

• Edge AI provides the essential infrastructure for processing data locally and in real-time, addressing latency, bandwidth, and privacy constraints inherent in continuous biosignal monitoring.22 It handles the ‘where’ and ‘when’ of computation.
• Hyperbolic Geometry offers a potentially superior representational space for capturing the inherent hierarchical or relational structures often found in biological data and cognitive processes.69 It addresses the ‘structure’ of the data.
• Associative Memory (perhaps instantiated as GGAM or similar models) provides the mechanism for learning, storing, and retrieving the complex connections and correlations between disparate data points within that structured representational space.23 It tackles the ‘connections’ within the data.

Theoretically, integrating these techniques could enable the construction of dynamic, highly personalized models of an individual’s psycho-physiological state. Such models could move beyond tracking isolated signals to capture the complex, time-varying interplay between the autonomic nervous system, central nervous system activity, hormonal fluctuations, and potentially even behavioral outputs. For instance, the model could learn how a specific individual’s HRV patterns, EDA responses, cortisol levels, and prefrontal cortex activity (via fNIRS/EEG) co-vary during periods of high cognitive load versus emotional stress, distinguishing between these states with greater nuance.

By modeling these intricate relationships and their dynamics over time, AI systems integrating these techniques could potentially infer higher-level internal states—such as levels of focus, specific emotional valences and intensities, cognitive fatigue, or even precursors to certain actions or shifts in conviction related to beliefs—with significantly greater accuracy and context-awareness than is possible by analyzing signals independently. This integrated approach holds the theoretical key to transforming the torrent of raw, multi-modal sensor data into a meaningful, actionable, and deeply personalized understanding of complex human internal states, paving the way for the applications envisioned in Society 5.0.

Section 4: Synthesis: Pathway to Human + Machine Societies 5.0

The convergence of advanced in vivo sensing, sophisticated AI integration techniques, and strategic national initiatives like Japan’s Moonshot program outlines a potential pathway towards realizing societies with deeply integrated human-machine capabilities, often conceptualized under frameworks like Society 5.0. This pathway involves leveraging technology to gain unprecedented insight into individual human states, enabling personalized support, augmented abilities, and enhanced well-being, while simultaneously navigating significant technical and ethical hurdles.

4.1 Integrating Advanced Sensors and AI: Creating a ‘Global Lens’ on Individual States

The envisioned technological pathway begins with the continuous acquisition of data from a diverse suite of in vivo sensors (Section 1), potentially including wearables monitoring ANS activity, implantables tracking neurochemicals or neural signals, and perhaps future nano- or quantum sensors providing cellular or molecular information. This raw data stream would then be processed in near real-time, likely utilizing Edge AI architectures to handle latency, privacy, and bandwidth constraints 22 (Section 3.2).

The next crucial step involves representing this heterogeneous data in a way that captures its inherent structure and relationships. Techniques leveraging hyperbolic geometry could provide a powerful representational space, particularly for modeling the hierarchical nature of biological systems and cognitive processes 70 (Section 3.3). Within this structured space, advanced associative memory models (potentially akin to GGAM) could then integrate the multi-modal data streams, learning the complex correlations and dynamic links between different physiological signals for a specific individual 23 (Section 3.4).

The output of this integrated AI system would be a dynamic, personalized model—a ‘global lens’—reflecting the individual’s current and evolving psycho-physiological state. This model would encapsulate not just isolated measurements but the relational intelligence derived from the interplay of multiple signals over time, as conceptualized by platforms like WiSE©.25 Furthermore, this pathway enables closed-loop systems. The insights generated by the AI’s ‘global lens’ could be used to provide real-time feedback or “nudges” to the individual (e.g., for stress management or focus enhancement) 25 or to control assistive technologies like the Cybernetic Avatars envisioned in Moonshot Goal 1 64, creating powerful human-machine synergies.

4.2 Potential for Deeper Understanding: Moving Beyond Proxies towards Models of Thought, Feeling, Action, and Belief

Current systems relying on in vivo sensors primarily model physiological proxies that correlate with relatively coarse states like overall stress, arousal level, or basic emotional valence.2 While valuable, this falls short of capturing the richness and nuance of human internal experience.

The future potential lies in the ability of advanced AI, fueled by richer, multi-modal data streams, to build more sophisticated and inferential models. By integrating data from direct neurochemical measurements (e.g., NE, ACh, DA, 5-HT via implantable optical or electrochemical sensors 7), high-resolution neural activity (via EEG, fNIRS, or neural implants 31), detailed autonomic responses (EDA, HRV 2), and hormonal levels (cortisol 26), relational AI models could potentially learn the complex, dynamic signatures underlying more specific internal states.

This could enable:

• Distinguishing between different types of stress (e.g., cognitive load vs. emotional threat).
• Identifying specific patterns of brain and body activity associated with focused attention versus mind-wandering.
• Tracking the trajectory of emotional responses with greater granularity (e.g., differentiating nuanced feelings beyond simple positive/negative).
• Potentially inferring intentions based on preparatory neural and physiological patterns, as targeted by Moonshot’s BMI projects.64
• Perhaps even detecting physiological shifts associated with changes in conviction or certainty related to beliefs, although directly measuring the content of a ‘belief’ remains a profound challenge likely requiring integration with language or behavioral data.

Achieving this level of understanding requires moving beyond simple correlation to model the complex, often non-linear, interactions between different biological systems over time. However, it is critical to emphasize that even these advanced models would still be inferential. Rigorous validation, correlating model outputs with detailed subjective reports, behavioral measures, and known neurobiological mechanisms, will be absolutely essential to ensure these inferred states accurately reflect human experience and are not merely complex artifacts of the data and algorithms.

4.3 Enabling Society 5.0: Personalized Health, Augmented Capabilities, Enhanced Well-being, and Human-Machine Synergy

The development of integrated sensor-AI systems capable of deep personalized understanding directly aligns with the strategic goals of Japan’s Moonshot program and the broader vision of Society 5.0.11 Potential applications span multiple domains:

• Ultra-Personalized Healthcare: Continuous monitoring via wearables or in-body CAs (Goal 1) could enable ultra-early disease prediction and intervention (a focus of Moonshot Goal 2 12), moving healthcare towards proactive and preventative models. Real-time physiological data could inform personalized treatment adjustments and health management strategies, aligning with concepts of Healthcare 5.0.47
• Augmented Human Capabilities: Seamless BMI control of Cybernetic Avatars (Goal 1) could allow individuals to overcome physical limitations, participate remotely in complex tasks, and potentially even share skills and experiences in novel ways.11 This could enhance productivity, inclusivity, and resilience in various sectors.
• Enhanced Well-being: Technologies derived from Goal 9 aim to directly promote “peace of mind and vitality” by providing individuals with objective insights into their mental states and offering personalized support or interventions to foster positive emotions, manage stress, and enhance curiosity or empathy.21 This could lead to improvements in mental health and overall quality of life.
• Human-Machine Synergy: The integration goes beyond simple monitoring or control towards genuine collaboration. Systems like WiSE© conceptualize direct human-machine synergy 25, while Moonshot Goal 3 explicitly targets the co-evolution of AI and robots acting alongside humans.12 Deep understanding of the human user’s state is fundamental to enabling machines to adapt, assist, and collaborate effectively.

4.4 Critical Challenges: Technical Hurdles, Ethical, Legal, and Social Implications (ELSI), Data Privacy and Security

Despite the transformative potential, the pathway towards these integrated human-machine systems is fraught with significant challenges that must be addressed:

• Technical Hurdles: Sensor technology still requires major advancements in accuracy, long-term stability, power efficiency, biocompatibility (especially for implants), and non-invasiveness.1 AI models need to become more robust, scalable, interpretable, and capable of handling the immense individual variability in physiological responses. Training these complex models requires access to massive, diverse, and well-annotated datasets, raising logistical and privacy issues.
• Ethical, Legal, and Social Implications (ELSI): The prospect of technologies capable of monitoring and potentially influencing internal thoughts and feelings raises profound ethical questions. Concerns include:

• Privacy: The intimate nature of brain and body data demands unprecedented levels of protection against surveillance by corporations or governments.
• Autonomy: Could continuous monitoring or AI-driven “nudges” undermine individual autonomy and decision-making?
• Manipulation/Discrimination: Could insights into internal states be used to manipulate individuals (e.g., in advertising, politics) or lead to discrimination (e.g., in employment, insurance)?
• Cognitive Liberty: Does individuals have a right to mental privacy and self-determination, free from technological intrusion?
• Equity: Ensuring equitable access to beneficial technologies and preventing the exacerbation of social inequalities. Recognizing these issues, frameworks like Society 5.0 and programs like Moonshot explicitly incorporate the need to address ELSI 14, but developing effective governance and ethical guidelines remains a critical ongoing task.

• Data Privacy and Security: Beyond broader ethical concerns, robust technical measures are needed to protect the highly sensitive biosignal data collected. This includes secure data storage, encrypted communication channels (especially for wireless implants and edge devices), and strong access control mechanisms to prevent breaches and unauthorized use.46

The journey towards Society 5.0, enabled by technologies for deep human understanding, is therefore not solely a technical endeavor. While significant engineering challenges remain in both sensor development and AI integration, the ethical, legal, and social dimensions are arguably paramount. Proactive, transparent, and multidisciplinary engagement involving technologists, ethicists, policymakers, and the public is essential to navigate these complex issues and ensure that these powerful technologies are developed and deployed in a manner that genuinely enhances human well-being and respects fundamental human rights. Failure to adequately address ELSI could undermine public trust and ultimately hinder the realization of this ambitious vision.

Conclusion and Future Outlook

The convergence of advanced in vivo sensing technologies, sophisticated AI integration methods, and strategic R&D initiatives like Japan’s Moonshot program points towards a future where technology enables a significantly deeper, more dynamic, and personalized understanding of the human condition. This report has analyzed the key components of this convergence: the diverse landscape of sensors capable of monitoring physiological proxies for internal states; the ambitious goals of Japan’s Moonshot program (particularly Goals 1 and 9) aimed at augmenting human capabilities and enhancing mental well-being within the Society 5.0 framework; and the potential of advanced AI techniques like Edge AI, hyperbolic geometry, and associative memory (as conceptualized in platforms like WiSE©) to fuse heterogeneous biosignals into coherent insights.

The potential benefits are profound, ranging from transformative advances in personalized healthcare and mental well-being support to the creation of novel human-machine interfaces that could overcome physical limitations and enable new forms of collaboration and skill sharing. The technologies explored hold the promise of moving beyond population averages to truly understand and support individuals based on their unique neurophysiological profiles and internal states.

However, this potential must be tempered by a realistic assessment of the significant challenges that lie ahead. Technically, substantial hurdles remain in developing sensors that are simultaneously accurate, reliable, non-invasive (or minimally invasive with excellent biocompatibility), and stable over the long term. Likewise, AI algorithms must evolve to handle the complexity, noise, and individuality inherent in biological data, while ensuring interpretability and robustness. The path towards the 2050 vision articulated by Moonshot will undoubtedly be iterative, requiring sustained investment and breakthroughs across multiple scientific and engineering disciplines.

Perhaps even more critical are the ethical, legal, and social implications. Technologies capable of peering into the physiological correlates of thought and feeling demand careful consideration of privacy, autonomy, potential for misuse, and equity. Establishing robust governance frameworks and fostering public discourse around these issues must proceed in parallel with technological development, guided by human-centered design principles 14 to ensure these powerful tools serve humanity’s best interests.

In conclusion, the integration of in vivo sensing and advanced AI, driven by strategic visions like Society 5.0, represents a frontier with the potential to fundamentally alter our relationship with technology and our understanding of ourselves. Successfully navigating this frontier requires not only technical ingenuity but also profound wisdom and foresight to harness its power responsibly for the betterment of individuals and society as a whole.

Works cited

1. In vivo imaging of vagal-induced myenteric plexus responses in gastrointestinal tract with an optical window – PubMed Central, accessed April 15, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC11405534/
2. Wireless Measurement of Sympathetic Arousal During in vivo Occupational Therapy Sessions – Frontiers, accessed April 15, 2025, https://www.frontiersin.org/journals/integrative-neuroscience/articles/10.3389/fnint.2020.539875/full
3. Measures of sympathetic and parasympathetic autonomic outflow from heartbeat dynamics, accessed April 15, 2025, https://journals.physiology.org/doi/full/10.1152/japplphysiol.00842.2017
4. Nanorobotic artificial blood components and its therapeutic applications: A minireview, accessed April 15, 2025, https://pubmed.ncbi.nlm.nih.gov/38282113/
5. Q-BiC: A Biocompatible Integrated Chip for in vitro and in vivo Spin-Based Quantum Sensing | PRX Life, accessed April 15, 2025, https://link.aps.org/doi/10.1103/PRXLife.3.013016
6. Implantable Biosensors for Musculoskeletal Health – PMC, accessed April 15, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC8977250/
7. Advancements in Brain Research: The In Vivo/In Vitro Electrochemical Detection of Neurochemicals – PMC – PubMed Central, accessed April 15, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10968235/
8. The Potential of Wearable Sensors for Detecting Cognitive Rumination: A Scoping Review, accessed April 15, 2025, https://www.mdpi.com/1424-8220/25/3/654
9. A genetically encoded fluorescent sensor for rapid and specific in vivo detection of norepinephrine – PMC – PubMed Central, accessed April 15, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC6533151/
10. (PDF) Novel Molecular and Nanosensors for In Vivo Sensing – ResearchGate, accessed April 15, 2025, https://www.researchgate.net/publication/255955787_Novel_Molecular_and_Nanosensors_for_In_Vivo_Sensing
11. Moonshot R&D Program Overview, accessed April 15, 2025, https://www.naro.go.jp/laboratory/brain/english/MoonshotLeaflet_EN_Goal1to10.pdf
12. Moonshot R&D｜TOP, accessed April 15, 2025, https://www.jst.go.jp/moonshot/en/
13. Moonshot Goals, accessed April 15, 2025, https://www8.cao.go.jp/cstp/english/moonshot/target_en.html
14. Society 5.0, accessed April 15, 2025, https://www8.cao.go.jp/cstp/english/society5_0/index.html
15. Overview of Moonshot R&D at JST – EEAS, accessed April 15, 2025, https://www.eeas.europa.eu/sites/default/files/eu_st_counsellor_meeting_20201022_1_kawabata.pdf
16. The Moonshot Research and Development Program: Challenging research and development towards the future – Open Access Government, accessed April 15, 2025, https://www.openaccessgovernment.org/the-moonshot-research-and-development-program/76139/
17. Japan’s new Science, Technology, and Innovation Basic Plan – DWIH Tokyo, accessed April 15, 2025, https://www.dwih-tokyo.org/files/2021/03/210309_Sato_Presentation-STI-BasicPlan_klein.pdf
18. The First Manga to Be Released in English from Neu World—A Science Communication Project under the Japan Cabinet Office’s Moonshot R&D Program Goal 1 “Internet of Brains (IoB)”, accessed April 15, 2025, https://brains.link/news/3998
19. Moonshot Research and Development Program | Japan Agency for Medical Research and Development – AMED, accessed April 15, 2025, https://www.amed.go.jp/en/program/list/18/03/001.html
20. Goal 1: Overcoming limitations of body, brain, space and time｜Program｜Moonshot R&D, accessed April 15, 2025, https://www.jst.go.jp/moonshot/en/program/goal1/
21. Goal 9: Increasing peace of mind and vitality｜Program｜Moonshot R&D, accessed April 15, 2025, https://www.jst.go.jp/moonshot/en/program/goal9/
22. What Is Edge AI? | IBM, accessed April 15, 2025, https://www.ibm.com/think/topics/edge-ai
23. Geometric associative memories applied to pattern restoration – SciELO México, accessed April 15, 2025, https://www.scielo.org.mx/pdf/rmf/v56n2/v56n2a10.pdf
24. Metasurfaces Assisted Twisted α-MoO 3 for Spinning Thermal Radiation – MDPI, accessed April 15, 2025, https://www.mdpi.com/2072-666X/13/10/1757
25. Ipvive, Inc. | Personalized Understanding of Complexity in an …, accessed April 15, 2025, https://www.ipvive.com/
26. Time-dependent effects of cortisol on selective attention and emotional interference: a functional MRI study – PubMed Central, accessed April 15, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC3428804/
27. Effects of neuromodulation on cognitive and emotional responses to psychosocial stressors in healthy humans – PubMed Central, accessed April 15, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC9860364/
28. New wearable sensor detects and interprets your emotions in real time, accessed April 15, 2025, https://www.thebrighterside.news/health/new-wearable-sensor-detects-and-interprets-your-emotions-in-real-time/
29. Wearable device reveals consumer emotions | MIT News, accessed April 15, 2025, https://news.mit.edu/2017/wearable-device-reveals-consumer-emotions-0712
30. Design considerations of a wearable electronic-skin for mental health and wellness: balancing biosignals and human factors | bioRxiv, accessed April 15, 2025, https://www.biorxiv.org/content/10.1101/2021.01.20.427496v1.full
31. What hemodynamic (fNIRS), electrophysiological (EEG) and autonomic integrated measures can tell us about emotional processing – PubMed, accessed April 15, 2025, https://pubmed.ncbi.nlm.nih.gov/25721430/
32. Neural correlates of heart rate variability during emotion | Request PDF – ResearchGate, accessed April 15, 2025, https://www.researchgate.net/publication/23244554_Neural_correlates_of_heart_rate_variability_during_emotion
33. Sensitive multicolor indicators for monitoring norepinephrine in vivo – PMC, accessed April 15, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC7615053/
34. Imaging in vivo acetylcholine release in the peripheral nervous system with a fluorescent nanosensor – PubMed Central, accessed April 15, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC8040656/
35. How can I measure brain acetylcholine levels in vivo? Advantages and caveats of commonly used approaches – PubMed Central, accessed April 15, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10616967/
36. Comparison of fluorescence biosensors and whole-cell patch clamp recording in detecting ACh, NE, and 5-HT – PMC – PubMed Central, accessed April 15, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10272411/
37. Cortisol Stress Response and in Vivo PET Imaging of Human Brain Serotonin 1A Receptor Binding – PubMed, accessed April 15, 2025, https://pubmed.ncbi.nlm.nih.gov/30927011/
38. Simultaneous Dopamine and Serotonin Monitoring in Freely Moving Crayfish Using a Wireless Electrochemical Sensing System – PubMed, accessed April 15, 2025, https://pubmed.ncbi.nlm.nih.gov/38713172/
39. Latest Trends in Electrochemical Sensors for Neurotransmitters: A Review – PubMed Central, accessed April 15, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC6539656/
40. Biomarkers and Detection Platforms for Human Health and Performance Monitoring: A Review – PMC – PubMed Central, accessed April 15, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC8895156/
41. The effect of EEG and fNIRS in the digital assessment and digital therapy of Alzheimer’s disease: a systematic review – PubMed, accessed April 15, 2025, https://pubmed.ncbi.nlm.nih.gov/38075282/
42. A Review of AI Cloud and Edge Sensors, Methods, and Applications for the Recognition of Emotional, Affective and Physiological States – MDPI, accessed April 15, 2025, https://www.mdpi.com/1424-8220/22/20/7824
43. Reducing Stress with Yoga: A Systematic Review Based on Multimodal Biosignals – PMC, accessed April 15, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10919405/
44. Quantum photonics sensing in biosystems – AIP Publishing, accessed April 15, 2025, https://pubs.aip.org/aip/app/article/10/1/010902/3329429/Quantum-photonics-sensing-in-biosystems
45. Quantum life science: biological nano quantum sensors, quantum technology-based hyperpolarized MRI/NMR, quantum biology, and quantum biotechnology – RSC Publishing, accessed April 15, 2025, https://pubs.rsc.org/en/content/articlehtml/2025/cs/d4cs00650j
46. A Survey on Wearable Sensors for Mental Health Monitoring – PMC, accessed April 15, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC9919280/
47. Current state of the art and future directions for implantable sensors in medical technology: Clinical needs and engineering challenges, accessed April 15, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10539032/
48. Emerging Materials and Technologies with Applications in Flexible Neural Implants: A Comprehensive Review of Current Issues with Neural Devices – PMC – PubMed Central, accessed April 15, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC11468537/
49. Monitoring norepinephrine release in vivo using next-generation GRAB NE sensors, accessed April 15, 2025, https://pubmed.ncbi.nlm.nih.gov/38547869/
50. Magnetically Driven Micro and Nanorobots – PMC – PubMed Central, accessed April 15, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC8154323/
51. Nanorobots in Medicine: Advancing Healthcare through Molecular Engineering: A Comprehensive Review | Nanotechnology – IgMin Research, accessed April 15, 2025, https://www.igminresearch.com/articles/html/igmin271
52. Advancements in Micro/Nanorobots in Medicine: Design, Actuation, and Transformative Application | ACS Omega, accessed April 15, 2025, https://pubs.acs.org/doi/10.1021/acsomega.4c09806
53. Smart nano-bio-devices – Institute for Bioengineering of Catalonia- Samuel Sánchez Ordóñez, accessed April 15, 2025, https://ibecbarcelona.eu/nanodevices
54. Functionalized Nanomaterials Capable of Crossing the Blood–Brain Barrier | ACS Nano, accessed April 15, 2025, https://pubs.acs.org/doi/10.1021/acsnano.3c10674
55. Publications | Joseph Wang – Nanoengineering – UCSD, accessed April 15, 2025, https://joewang.ucsd.edu/index.php/publications/
56. Quantum Sensing Testbed | TNO, accessed April 15, 2025, https://www.tno.nl/en/technology-science/labs/quantum-sensing-testbed/
57. Quantum life science: biological nano quantum sensors, quantum technology-based hyperpolarized MRI/NMR, quantum biology, and quantum biotechnology – Chemical Society Reviews (RSC Publishing), accessed April 15, 2025, https://pubs.rsc.org/en/content/articlelanding/2025/cs/d4cs00650j
58. (PDF) Recent Advances in Quantum Biosensing Technologies – ResearchGate, accessed April 15, 2025, https://www.researchgate.net/publication/386450857_Recent_Advances_in_Quantum_Biosensing_Technologies
59. Quantum sensors for biomedical applications – PMC, accessed April 15, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC9896461/
60. A wealth of joint project ideas sparked at the Moonshot Workshop on AI and Robotics in Tokyo – Swissnex, accessed April 15, 2025, https://swissnex.org/news/2nd_eu-jp_moonshot_workshop/
61. R&D Concept of Goal1, accessed April 15, 2025, https://www8.cao.go.jp/cstp/english/moonshot/concept1_en.pdf
62. Moonshot R&D Program Overview, accessed April 15, 2025, https://www8.cao.go.jp/cstp/moonshot/pr/2p_leaflet_jp_2406en.pdf
63. Moonshot R&D Leaflet (Goal 1-9), accessed April 15, 2025, https://www.naro.go.jp/laboratory/brain/english/MoonshotLeaflet_EN_Goal1to7.pdf
64. Goal 1: KANAI Ryota Project｜Moonshot R&D, accessed April 15, 2025, https://www.jst.go.jp/moonshot/en/program/goal1/12_kanai.html
65. R&D Concept of Goal9, accessed April 15, 2025, https://www8.cao.go.jp/cstp/english/moonshot/concept9_en.pdf
66. R&D Concept of Moonshot Goal 9, accessed April 15, 2025, https://www.jst.go.jp/moonshot/en/application/202111/files/presentation_g9.pdf
67. A beginner’s guide to AI Edge computing: How it works and its benefits | Flexential, accessed April 15, 2025, https://www.flexential.com/resources/blog/beginners-guide-ai-edge-computing
68. AI at the Edge, accessed April 15, 2025, https://6371311.fs1.hubspotusercontent-na1.net/hubfs/6371311/Content%20and%20Docs/AI%20at%20the%20Edge%20-%20full%20book%20-%20compressed.pdf
69. marlin-codes/Awesome-Hyperbolic-Representation-and-Deep-Learning – GitHub, accessed April 15, 2025, https://github.com/marlin-codes/Awesome-Hyperbolic-Representation-and-Deep-Learning
70. [2204.13704] Hyperbolic Hierarchical Knowledge Graph Embeddings for Link Prediction in Low Dimensions – arXiv, accessed April 15, 2025, https://arxiv.org/abs/2204.13704
71. [2411.03622] Fully Hyperbolic Rotation for Knowledge Graph Embedding – arXiv, accessed April 15, 2025, https://arxiv.org/abs/2411.03622
72. Fully Hyperbolic Rotation for Knowledge Graph Embedding arXiv:2411.03622v2 [cs.AI] 7 Nov 2024, accessed April 15, 2025, https://arxiv.org/pdf/2411.03622?
73. What is Associative Memory? – Moveworks, accessed April 15, 2025, https://www.moveworks.com/us/en/resources/ai-terms-glossary/associative-memory
74. Associative Memory – GeeksforGeeks, accessed April 15, 2025, https://www.geeksforgeeks.org/associative-memory/
75. Scaling Laws for Associative Memories – OpenReview, accessed April 15, 2025, https://openreview.net/forum?id=Tzh6xAJSll

Moonshot Goal 9: Realization of a mentally healthy and dynamic society by increasing peace of mind and vitality by 2050, accessed April 15, 2025, https://www8.cao.go.jp/cstp/english/moonshot/sub9_en.html